Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 19.50
0.00 (0.00%)
At close: Jan 22, 2026
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 26.92 million as of January 22, 2026. Its market cap has decreased by -4.22% in one year.
Market Cap
26.92M
Enterprise Value
23.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
19.50
Market Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 26.92M, an increase of 209.68%. That is a compound annual growth rate of 5.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 26.92M | 30.00% |
| Dec 31, 2025 | 20.71M | -32.34% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SkinBioTherapeutics | 48.52M |
| Hemogenyx Pharmaceuticals | 41.56M |
| hVIVO | 37.76M |
| Ondine Biomedical | 35.54M |
| ImmuPharma | 34.69M |
| Poolbeg Pharma | 32.42M |
| Arecor Therapeutics | 31.15M |
| Aptamer Group | 25.62M |